Bendamustine Hydrochloride for the Treatment of Relapsed or Refractory Acute Leukemia
- Study Title
- Study of Bendamustine Hydrochloride for the Treatment of Pediatric Patients With Relapsed or Refractory Acute Leukemia
- Teva Identifier
- C18083/2046 | 2010-020768-40
- ClinicalTrials.gov Identifier
- NCT01088984
- Study Status
- Completed
- Trial Condition(s)
- Leukemia
- Interventions
- Drug: Bendamustine
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Child, Adult
- Age Range
- 1 Year to 20 Years
- Trial Duration
- 08/01/2010 - 08/01/2011
- Phase
- Phase 1/2
